362 related articles for article (PubMed ID: 29695767)
1. Cutaneous neurofibromas in the genomics era: current understanding and open questions.
Allaway RJ; Gosline SJC; La Rosa S; Knight P; Bakker A; Guinney J; Le LQ
Br J Cancer; 2018 Jun; 118(12):1539-1548. PubMed ID: 29695767
[TBL] [Abstract][Full Text] [Related]
2. New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
Williams KB; Largaespada DA
Genes (Basel); 2020 Apr; 11(5):. PubMed ID: 32353955
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.
Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M
Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606
[TBL] [Abstract][Full Text] [Related]
4. Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.
Thomas L; Spurlock G; Eudall C; Thomas NS; Mort M; Hamby SE; Chuzhanova N; Brems H; Legius E; Cooper DN; Upadhyaya M
Eur J Hum Genet; 2012 Apr; 20(4):411-9. PubMed ID: 22108604
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal Loss of
Chen Z; Mo J; Brosseau JP; Shipman T; Wang Y; Liao CP; Cooper JM; Allaway RJ; Gosline SJC; Guinney J; Carroll TJ; Le LQ
Cancer Discov; 2019 Jan; 9(1):114-129. PubMed ID: 30348677
[TBL] [Abstract][Full Text] [Related]
6. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
Brossier NM; Carroll SL
Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
[TBL] [Abstract][Full Text] [Related]
7. Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with
Radomska KJ; Coulpier F; Gresset A; Schmitt A; Debbiche A; Lemoine S; Wolkenstein P; Vallat JM; Charnay P; Topilko P
Cancer Discov; 2019 Jan; 9(1):130-147. PubMed ID: 30348676
[TBL] [Abstract][Full Text] [Related]
8. Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient.
Emmerich D; Zemojtel T; Hecht J; Krawitz P; Spielmann M; Kühnisch J; Kobus K; Osswald M; Heinrich V; Berlien P; Müller U; Mautner VF; Wimmer K; Robinson PN; Vingron M; Tinschert S; Mundlos S; Kolanczyk M
Eur J Hum Genet; 2015 Jun; 23(6):870-3. PubMed ID: 25293717
[TBL] [Abstract][Full Text] [Related]
9. The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin.
Rice FL; Houk G; Wymer JP; Gosline SJC; Guinney J; Wu J; Ratner N; Jankowski MP; La Rosa S; Dockum M; Storey JR; Carroll SL; Albrecht PJ; Riccardi VM
PLoS One; 2019; 14(5):e0216527. PubMed ID: 31107888
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
11. The NF1 somatic mutational landscape in sporadic human cancers.
Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
[TBL] [Abstract][Full Text] [Related]
12. Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.
Staedtke V; Topilko P; Le LQ; Grimes K; Largaespada DA; Cagan RL; Steensma MR; Stemmer-Rachamimov A; Blakeley JO; Rhodes SD; Ly I; Romo CG; Lee SY; Serra E
J Invest Dermatol; 2023 Aug; 143(8):1378-1387. PubMed ID: 37330719
[TBL] [Abstract][Full Text] [Related]
13. Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome?
Fareez F; Wang BH; Brain I; Lu JQ
Pathology; 2023 Apr; 55(3):302-314. PubMed ID: 36774237
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in neurofibromatosis type 1.
Arun D; Gutmann DH
Curr Opin Neurol; 2004 Apr; 17(2):101-5. PubMed ID: 15021234
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.
Le LQ; Parada LF
Oncogene; 2007 Jul; 26(32):4609-16. PubMed ID: 17297459
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.
Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L
Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapeutic targets for neurofibromatosis type 1.
Walker JA; Upadhyaya M
Expert Opin Ther Targets; 2018 May; 22(5):419-437. PubMed ID: 29667529
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.
Longo JF; Weber SM; Turner-Ivey BP; Carroll SL
Adv Anat Pathol; 2018 Sep; 25(5):353-368. PubMed ID: 29762158
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]